Women who are sexual contacts of men with urethritis will be identified to determine the prevalence of silent endometritis, its """"""""natural history"""""""", and its response to medical therapy. (""""""""Natural history"""""""" is defined here as the course of silent endometritis treated as uncomplicated cervicitis.) We will enroll a subgroup of the core patient group, as epidemiologically defined in Core 2 - female contacts of male patients with urethritis of known cause. The natural history component will compare these women documented to have cervical infection with N. gonorrhoeae and/or C. trachomatis (study group) to a demographically similar group who are uninfected (control group). We will determine the prevalence of endometritis diagnosed histopathologically in each group and the rate of resolution of endometritis after identical treatment. After endometrial biopsy, both groups of patients will receive regimens of ceftriaxone and seven days doxycycline. Using two follow-up biopsies - one at 4 weeks and one at 8 weeks, we will determine whether the rate of resolution of endometrial inflammation and secondary pathologic changes are different in the two groups. The treatment trial will compare the same group of patients with documented cervical infection (study group) receiving standard treatment for cervicitis with ceftriaxone and doxycycline, to a similarly infected group who will receive ceftriaxone and 14 days (instead of 7) of doxycycline (extended therapy group). Assignment to the two groups will be randomized and double blinded. Extent of improvement and frequency of cure defined by rigorous histopathologic criteria will be compared in each group. Patients' response to therapy will be assessed by repeat endometrial biopsies and follow-up cultures at 4 and 8 weeks after entry. The role of non-chlamydial, non-gonococcal bacterial infection in the persistence of endometrial infection and inflammation and the role that primary pathogens such as N. gonorrhoeae and C. trachomatis play in persistence of endometritis with other organisms, will also be determined for the three groups.

Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Boston Medical Center
Department
Type
DUNS #
005492160
City
Boston
State
MA
Country
United States
Zip Code
02118
Muhlecker, W; Gulati, S; McQuillen, D P et al. (1999) An essential saccharide binding domain for the mAb 2C7 established for Neisseria gonorrhoeae LOS by ES-MS and MSn. Glycobiology 9:157-71
McQuillen, D P; Gulati, S; Ram, S et al. (1999) Complement processing and immunoglobulin binding to Neisseria gonorrhoeae determined in vitro simulates in vivo effects. J Infect Dis 179:124-35
Lo, S K; Golenbock, D T; Sass, P M et al. (1997) Engagement of the Lewis X antigen (CD15) results in monocyte activation. Blood 89:307-14
Qureshi, N; Kaltashov, I; Walker, K et al. (1997) Structure of the monophosphoryl lipid A moiety obtained from the lipopolysaccharide of Chlamydia trachomatis. J Biol Chem 272:10594-600
Gulati, S; McQuillen, D P; Mandrell, R E et al. (1996) Immunogenicity of Neisseria gonorrhoeae lipooligosaccharide epitope 2C7, widely expressed in vivo with no immunochemical similarity to human glycosphingolipids. J Infect Dis 174:1223-37
Gulati, S; McQuillen, D P; Sharon, J et al. (1996) Experimental immunization with a monoclonal anti-idiotope antibody that mimics the Neisseria gonorrhoeae lipooligosaccharide epitope 2C7. J Infect Dis 174:1238-48
Ingalls, R R; Golenbock, D T (1995) CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide. J Exp Med 181:1473-9
Golenbock, D T; Bach, R R; Lichenstein, H et al. (1995) Soluble CD14 promotes LPS activation of CD14-deficient PNH monocytes and endothelial cells. J Lab Clin Med 125:662-71
Delude, R L; Savedra Jr, R; Zhao, H et al. (1995) CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. Proc Natl Acad Sci U S A 92:9288-92
Ingalls, R R; Rice, P A; Qureshi, N et al. (1995) The inflammatory cytokine response to Chlamydia trachomatis infection is endotoxin mediated. Infect Immun 63:3125-30

Showing the most recent 10 out of 15 publications